Science Strategic Ownership

SSAA
 Stock
  

USD 10.05  0.02  0.20%   

Some institutional investors establish a significant position in stocks such as Science Strategic in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Science Strategic, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Additionally, take a look at World Market Map.
  
Science Strategic maintains a total of 31.05 Million outstanding shares. The majority of Science Strategic outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Science Strategic to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Science Strategic. Please pay attention to any change in the institutional holdings of Science Strategic Acquisition as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Science Stock Ownership Analysis

About 92.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Science Strategic had not issued any dividends in recent years. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses in the direct-to-consumer brands, D2C services, and mobile and social entertainment sectors. The company was incorporated in 2020 and is based in Santa Monica, California. Science Strategic is traded on NASDAQ Exchange in the United States. To find out more about Science Strategic Acquisition contact Michael Jones at 310 393 3024 or learn more at https://www.science-inc.com/ssaa.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Science Strategic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Science Strategic's short interest history, or implied volatility extrapolated from Science Strategic options trading.

Currently Active Assets on Macroaxis

Additionally, take a look at World Market Map. Note that the Science Strategic information on this page should be used as a complementary analysis to other Science Strategic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Science Stock analysis

When running Science Strategic price analysis, check to measure Science Strategic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science Strategic is operating at the current time. Most of Science Strategic's value examination focuses on studying past and present price action to predict the probability of Science Strategic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Science Strategic's price. Additionally, you may evaluate how the addition of Science Strategic to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Is Science Strategic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Strategic. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Strategic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.01) 
Market Capitalization
390.1 M
Return On Assets
(0.0118) 
The market value of Science Strategic is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Strategic's value that differs from its market value or its book value, called intrinsic value, which is Science Strategic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Strategic's market value can be influenced by many factors that don't directly affect Science Strategic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Science Strategic's value and its price as these two are different measures arrived at by different means. Investors typically determine Science Strategic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Strategic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.